Drreddys Laboratories | RDY - Ordinary Share Capital


Drreddys Laboratories reported INR832.69M in Ordinary Share Capital for its fiscal quarter ending in March of 2026.





Ordinary Share Capital Change Date
ANI Pharmaceuticals USD 22.49M 760K Dec/2025
Aurora Cannabis CAD 58.95M 2.24M Mar/2026
Bayer EUR 982.42M 0 Mar/2026
Canopy Growth CAD 422.07M 53.78M Mar/2026
Cipla INR 807.78M 17K Mar/2026
Corcept Therapeutics USD 107.33M 1.36M Mar/2026
Drreddys Laboratories INR 832.69M 123K Mar/2026
GlaxoSmithKline GBP 4.08B 20.6M Jun/2026
Hikma Pharmaceutical USD 221.89M 181.89M Dec/2025
Lonza CHF 68.64M 0 Dec/2025
Novartis USD 1.9B 7.38M Jun/2026
Pacira USD 39.31M 1.81M Mar/2026
Phibro Animal Health USD 40.48M 0 Dec/2025
Prestige Brands USD 47.32M 765K Dec/2025
Richter Gedeon HUF 182.86M 3.51M Mar/2026
Sun Pharmaceuticals INR 2.4B 0 Mar/2026
Supernus Pharmaceuticals USD 58.16M 124K Jun/2026
Teva Pharmaceutical Industries USD 1.16B 1000K Jun/2026